BLINCYTO 35/38.5 mcg
- Name: BLINCYTO
- Generic Name: Blinatumomab
- Strength: 35 mcg | 38.5 Single-Dose Vial
- Manufactured : Amgen Inc
Blincyto contains Blinatumomab is a bispecific CD19-directed CD3 T-cell engager. Blincyto uses are:
- B-cell precursor acute lymphoblastic leukemia in first or second complete remission with minimal residual disease greater than or equal 0.1%.
- Relapsed or refractory B-cell precursor ALL (Acute Lymphoblastic Leukemia).
Note: – Blincyto is an FDA approved drug.
- Assess patients with blinatumomab injection for signs and symptoms of neurological toxicities. Advise outpatients on Blinatumomab to contact their health specialist if they develop signs/symptoms of neurological toxicities.
- Monitor patients with Blincyto doses for signs and symptoms of infection and treat appropriately.
- Assess laboratory parameters (including, but not limited to, WBC count and absolute neutrophil count) during blinatumomab infusion. Interrupt this medication if prolonged neutropenia occurs.
- Monitor aspartate aminotransferase (AST), alanine aminotransferase (ALT), gamma-glutamyl transferase (GGT), and total blood bilirubin before the start of and while on Blincyto 35 mcg treatment.
- Assess patients who develop signs of pancreatitis. Management of pancreatitis may need either temporary interruption or discontinuation of Blincyto injection and dexamethasone.
- Healthcare professionals recommend not to have vaccination with live virus vaccines for at least before 2 weeks Blinatumomab 35 mcg treatment, during treatment, and until immune recovery following the last cycle of Blinatumomab.
What documents are required to import Blincyto?
Blincyto (Blinatumomab) injection can be imported by patients or government hospitals on behalf of patients. The following documentation is required to import the product:
- A valid prescription from a qualified doctor.
- Patient’s diagnostic reports.
- Patient’s ID proof (issued by the Government of the respective country).
How is the order confirmed?
The order will be confirmed only after the receipt of:
- A valid prescription from a doctor.
- Import permit if applicable.
Is Blincyto available worldwide?
Blincyto (Blinatumomab) injection is a prescription pharmaceutical drug that legally requires a medical prescription for dispensation.
Indian Pharma Network (IPN) facilitates the import of critical medications like Blincyto (Blinatumomab) globally, ensuring the named patient supply (NPS). IPN is the facilitator that provides essential support for:
- Availability of Blincyto (Afghanistan, Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, and Sri Lanka).
- BLINCYTO Available in India (Noida, Delhi, Mumbai, Gurgaon, Lucknow, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore and Pune etc
- Determining Medicine Price.
- Sourcing genuine and reliable sources from the USA, Canada, Europe, and Australia.
- Ensuring 100% transparency.
Blincyto (Blinatumomab) injection can be made available to patients, doctors, and hospitals in various countries across the globe. The order will be confirmed only after receiving a valid prescription from the doctor and, if required, an import permit.
Indian Pharma Network (IPN) can facilitate the supply of Blincyto (prescription medicine) to locations worldwide while adhering to legal requirements (if applicable).
We assure quality and worldwide delivery as per the buyer’s specifications.
Indian Pharma Network is proficient in sourcing Blincyto (Blinatumomab) injection from around the world and has the capability to supply it. We offer global access to the best available treatment for our customers worldwide in countries like Afghanistan, Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, and Sri Lanka.
Indian Pharma Network (IPN) is committed to dispensing any valid prescription promptly. All prescriptions are dispensed and verified by registered pharmacists and are dispatched only to the patient’s address. Your health and well-being are our top priorities
Indian Pharma Network helps you to connect with potential distributors, wholesalers, suppliers and dealers of Blincyto in India.
What is the Generic Name for the trade name drug Blincyto®?
Blincyto is the trade name for the drug Blinatumomab.
Is Blincyto® approved by the FDA?
What kind of drug is Blincyto?
What is the dosage and form of Blincyto® available?
What are the ingredients in the medicine Blincyto?
Is Blincyto chemotherapy?
How much does Blincyto® cost in India?
What is the latest FDA approval for Blincyto?
How effective is Blincyto in the consolidation phase of B-ALL treatment?
What makes Blincyto a unique treatment option for B-ALL?
What are the new findings from recent clinical trials regarding Blincyto?
Is Blincyto available in Asia?
How can I get Blincyto injection?
How does Blincyto fit into the current treatment landscape for B-ALL?
Where is Blincyto available in India?
Blincyto available in India (Noida, Delhi, Mumbai, Gurgaon, Lucknow, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore and Pune etc
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.